chymase is able to degrade apoE in HDL particles. Because apoE is involved in the development of hypertriglyceridemia in humans, and circulating apoE levels have been shown to increase in hypertriglyceridemic (HTG) patients (9) , blood samples were obtained from two HTG subjects (Helsinki University Hospital) after overnight fasting. Blood was drained into pre-cooled tubes containing Kabikinase at a final concentration of 150 IU/mL of blood. Plasma was obtained by centrifuging blood at 48C for 30 min and kept at -708C until analyzed. We used as the source of chymase the granule remnants isolated from rat serosal mast cells. Importantly, both rat and human chymase cleave apoA-I in preb-migrating HDL and generate identical proteolytic patterns (10) .
First, we evaluated the ability of granule remnants to proteolyze HDL in control plasma obtained from normolipidemic subjects by adding 125 I-labeled HDL to the incubation mixtures and measuring the production of 125 I-labeled TCA-soluble degradation products. For that, 50% of plasma (i.e., diluted with buffer) was treated with 30 mg of chymase-containing granule remnants at 378C for 1 h and 6 h, respectively. Incubation was stopped by centrifugation at 48C, 10,000 rpm (8900=g) for 5 min to sediment the granule remnants. Under these conditions chymase degraded 2.2% and 3.7% of the 125 I-labeled apolipoproteins present in HDL. Next, we evaluated by Western blotting the distribution of apoE-and apoA-Icontaining lipoproteins (designated as LpE and LpA-I, respectively) in such incubation mixtures. Figure 1 shows representative results of two-dimensional polyacrylamide gradient gel electrophoresis (first and second dimension as indicated by arrows) analyses of LpE (panels A-D) and LpA-I (panels E-H) of plasma from subject 1 ( Table 1) after treatment with chymase. In the control (non-treated) plasma, apoE was associated to particles having either b-or a-electrophoretic mobility in the first dimension, and various mobilities in the second dimension reflecting heterogeneous particle sizes (panel A). Compatible with previous findings (11), a-LpE co-migrated with a-LpA-I (compare panels A and E). Importantly, incubation of plasma for 1 h with mast cell granules was sufficient to degrade apoE in all HDL subpopulations, independently of their electrophoretic mobility and sizes (panel B). Also, practically all of preb 1 LpA-I particles, known for their high sensitivity to chymase degradation (12) , were degraded during this short time of incubation with chymase (panel F). In sharp contrast, only minor degradation of a-LpA-I by chymase was achieved even after the longest incubation Plasma (30 mL) was incubated with chymase for 1 h and 6 h at 378C in the absence or presence of 30 mg of chymasecontaining granule remnants (40 BTEE units) in 60 mL of 5 mM Tris-HCl containing 150 mM NaCl, 1 mM EDTA, pH 7.4.
Incubation was terminated by centrifuging the vials at 10,000 rpm (8900=g) to sediment the granule remnants, and the supernatant was kept at -708C until analysis. Aliquots (40 mL) of the incubation mixtures were separated by two-dimensional electrophoresis in the sequence agarose gel electrophoresis™non-denaturing polyacrylamide gradient gel electrophoresis. After electroblotting to a nitrocellulose membrane, apoE-and apoA-I-containing particles were detected with polyclonal antisera against human apoE or apoA-I and horseradish peroxidase-conjugated second antibodies, as previously described (11). Similar results were obtained with plasma of subject 2 (data not shown). The degradation of apoE in a-migrating HDL found here could partly explain why chymase strongly impairs the ability of mature HDL to act as cellular cholesterol acceptor, despite that only a low degree of apoA-I proteolysis is achieved (13) . In addition to mast cells, human atherosclerotic lesions contain endothelial cells, smooth muscle cells and inflammatory cells, such as macrophages and T lymphocytes that also secrete proteases into the inflammatory intima. Recently, apoA-I breakdown products and selective preb-HDL degradation have been found in the circulation of patients with acute myocardial infarction (14) . This finding supports the notion that extracellular proteolysis may occur in conditions of protease burden likely to be present in the inflamed intima. Importantly, the gain in resistance of mast cell-derived chymase against the serpins by its association with the heparin proteoglycans of the mast cell granules (6) strongly suggests that chymase may be one of the intimal proteases capable of degrading HDL in vivo in the extracellular fluid of the intima. As HDL particles in human atherosclerotic lesions are enriched in apoE (15), we conclude that extracellular proteolysis of apoE-containing HDL is a novel inhibitory principle that may interfere with the initiation of reverse cholesterol transport in the atherosclerotic arterial intima.
